The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
Open accessAbstract
The blood vessels of cancerous tumours are leaky1–3 and poorly organized4–7. This can increase the interstitial fluid pressure (IFP) inside tumours and reduce blood supply to them, which impairs drug delivery8–9. Anti-angiogenic therapies – which “normalize” the abnormal blood vessels in tumours by making them less leaky – have been shown to improve the delivery and effectiveness of chemotherapeutics with low molecular-weights10, but it remains unclear whether normalizing tumour vessels can improve the delivery of nanomedicines. Here we show that repairing the abnormal vessels in mammary tumours, by blocking vascular endothelial growth factor (VEGF) receptor-2, improves the delivery of small nanoparticles (12nm diameter) while hindering the delivery of large nanoparticles (125nm diameter). We utilize a mathematical model to show that reducing vessel wall pore sizes through normalization decreases IFP in tumours, allowing small nanoparticles to enter them more rapidly. However, increased steric and hydrodynamic hindrances, also associated with smaller pores, make it more difficult for large nanoparticles to enter tumours. Our results further suggest that smaller (~12nm) nanomedicines are ideal for cancer therapy, owing to superior tumour penetration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, the research group administered a combination of Doxil (around 125 nm in size) or Abaxane (around 12 nm in size) in breast tumor-bearing mice and observed a significant (around threefold) accumulation of smaller nanoparticles [26].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The uniformly elevated IFP in tumor center is responsible for inhibiting drug delivery [172, 178, 186] while the steep pressure gradients at the periphery favors tumor growth and metastasis[154,[187][188][189][190].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [186]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Self-citationMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Self-citationDelivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,265
Self-citationRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Self-citationWillett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,985
Self-citationBatchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Self-citationOpenings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Self-citationNormalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Self-citation
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,000
Passive Targeting and the Enhanced Permeability and Retention (EPR) Effect
Onzi, G. R., Guterres, S. S., Pohlmann, A. R., & Frank, L. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-51519-5_108-1 · Cited by 33
Akinpelu, A., Akinsipe, T., Avila, L. A., Arnold, R. D., & Mistriotis, P. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10166-x · Cited by 33
Image-based predictive modelling frameworks for personalised drug delivery in cancer therapy
Bhandari, A., Gu, B., Kashkooli, F. M., & Zhan, W. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.004 · Cited by 30
Nanogel-based nitric oxide-driven nanomotor for deep tissue penetration and enhanced tumor therapy
Wang, J., Liu, J., Sümbelli, Y., Shao, J., Shi, X., & van Hest, J. C. M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.021 · Cited by 30
Interstitial Flow in Cancerous Tissue: Effect of Considering Remodeled Capillary Network
Sefidgar, M., & Soltani, M. (2014) · Journal of Tissue Science & Engineering · doi:10.4172/2157-7552.s4-003 · Cited by 30
Hu, X., Yang, P., He, J., Liang, R., Niu, D., Wang, H., & Li, Y. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01268c · Cited by 30
Losartan treatment attenuates tumor-induced myocardial dysfunction
Stevens, S. C. W., Velten, M., Youtz, D. J., Clark, Y. Y., Jing, R., Reiser, P. J., Bicer, S., Devine, R. D., McCarthy, D. O., & Wold, L. E. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.05.007 · Cited by 30
Xu, H., Fan, Z.-L., Zhuge, D., Shen, B., Jin, B., Xiao, J., Lu, C., & Zhao, Y. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.07.019 · Cited by 31
Vavourakis, V., Stylianopoulos, T., & Wijeratne, P. A. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006460 · Cited by 30
Self-citationHarkos, C., Svensson, S. F., Emblem, K. E., & Stylianopoulos, T. (2022) · Cancers · doi:10.3390/cancers14040884 · Cited by 30
Self-citationZhang, W., Hu, X., Cheng, W., Zhang, L., Chen, Y., Fu, Q., Liu, L., & Fan, S. (2025) · BMEMat · doi:10.1002/bmm2.70019 · Cited by 30
License for destruction: Tumor-specific cytokine targeting
Johansson, A., Hamzah, J., & Ganß, R. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.10.002 · Cited by 29
Zhao, C., Shao, L., Lu, J., Deng, X., Tong, Y., & Wu, Y. F. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b01908 · Cited by 29
Liu, Y., Li, L., Liu, J., Yang, M., Wang, H., Chu, X., Zhou, J., Huo, M., & Yin, T. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120481 · Cited by 29
Nanomedicine: The Promise and Challenges in Cancer Chemotherapy
Naguib, Y. W., & Cui, Z. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-8739-0_11 · Cited by 28
Oh, G., Yoo, S. W., Jung, Y., Ryu, Y., Park, Y., Kim, S., Kim, K. H., Kim, S., Myung, S., & Chung, E. (2014) · Biomedical Optics Express · doi:10.1364/boe.5.001677 · Cited by 29
Vizirianakis, I. S., Mystridis, G. A., Avgoustakis, K., Fatouros, D. G., & Spanakis, M. (2016) · Oncology Reports · doi:10.3892/or.2016.4575 · Cited by 31
Extension of a multiphase tumour growth model to study nanoparticle delivery to solid tumours
Wirthl, B., Kremheller, J., Schrefler, B. A., & Wall, W. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228443 · Cited by 29
The spatiotemporal journey of nanomedicines in solid tumors on their therapeutic efficacy
Qin, M., Xia, H., Xu, W., Chen, B., & Wang, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115137 · Cited by 31
Nanomedicine in Chemoradiation
Miller, S., & Wang, A. Z. (2013) · Therapeutic Delivery · doi:10.4155/tde.12.147 · Cited by 28
Šírová, M., Strohalm, J., Chytil, P., Lidický, O., Tomala, J., Řı́hová, B., & Etrych, T. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.004 · Cited by 28
Advancements in Nanomedicine for Multiple Myeloma
Detappe, A., Bustoros, M. W., Mouhieddine, T. H., & Ghoroghchian, P. P. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.04.005 · Cited by 27
Dendrimer-based magnetic resonance imaging agents for brain cancer
Ding, L., Lyu, Z., Dhumal, D. M., Kao, C., Bernard, M., & Peng, L. (2018) · Science China Materials · doi:10.1007/s40843-018-9323-6 · Cited by 29
Li, S., Yuan, C., Chen, J., Chen, D., Chen, Z., Chen, W., Yan, S., Hu, P., Xue, J., Li, R., et al. (2019) · Theranostics · doi:10.7150/thno.29445 · Cited by 28
Zhou, D., Liu, S., Hu, Y. J., Yang, S., Zhao, B., Zheng, K., Zhang, Y., He, P., Mo, G., & Li, Y. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00143k · Cited by 28
The Influence of Chronic Liver Diseases on Hepatic Vasculature: A Liver-on-a-chip Review
Özkan, A., Stolley, D. L., Cressman, E. N. K., McMillin, M., DeMorrow, S., Yankeelov, T. E., & Rylander, M. N. (2020) · Micromachines · doi:10.3390/mi11050487 · Cited by 28
Selective Targeting of Cancer Signaling Pathways with Nanomedicines: Challenges and Progress
Barkat, H. A., Das, S. S., Barkat, M. A., Beg, S., & Hadi, H. A. (2020) · Future Oncology · doi:10.2217/fon-2020-0198 · Cited by 29
Effect of Acoustic Radiation Force on the Distribution of Nanoparticles in Solid Tumors
Afadzi, M., Myhre, O. F., Yemane, P. T., Bjørkøy, A., TORP, S. H., van Wamel, A. J. E. T., Lélu, S., Angelsen, B., & Davies, C. D. L. (2020) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2020.3027072 · Cited by 28
Huang, L., Asghar, S., Zhu, T., Ye, P., Hu, Z., Chen, Z., & Xiao, Y. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1950685 · Cited by 28
Meher, N., Seo, K., Wang, S., Bidkar, A. P., Fogarty, M., Dhrona, S., Huang, X., Tang, R., Blaha, C., Evans, M. J., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c16383 · Cited by 30
Chen, L., Cao, L., Zhan, M., Li, J., Wang, D., Laurent, R., Mignani, S. M., Caminade, A., Majoral, J., & Shi, X. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00197 · Cited by 29
Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future Directions
Vallejo, F. A., Sigdel, G., Véliz, E. A., Leblanc, R. M., Vanni, S., & Graham, R. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119562 · Cited by 28
Yoshizawa, Y., Ogawara, K., Fushimi, A., Abe, S., Ishikawa, K., Araki, T., Molema, G., Kimura, T., & Higaki, K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300318q · Cited by 28
Tsai, M., Peng, C., Yang, S., & Shieh, M. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00315 · Cited by 28
Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines
Tang, Y., Yu, Z., Lü, X., Fan, Q., & Huang, W. (2022) · Advanced Science · doi:10.1002/advs.202103148 · Cited by 26
Chen, E., Zeng, Z., & Zhou, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189198 · Cited by 30
Factors governing tumor penetration of nanomedicines: intrinsic and extrinsic determinants
Shin, D., Choi, J., Park, B., Kim, S. H., & Shim, M. K. (2026) · Nanoscale · doi:10.1039/d5nr04462f · Cited by 31
Sawada, J., Li, F., & Komatsu, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.591511 · Cited by 27
Why are nanoparticles trapped at cell junctions when the cell density is high?
Yue, T., Zhou, H., Sun, H., Li, S., Zhang, X., Cao, D., Yi, X., & Yan, B. (2019) · Nanoscale · doi:10.1039/c9nr01024f · Cited by 27
Shuai, Q., Zhao, G., Lian, X., Wan, J., Cen, B., Zhang, W., Liu, J., Su, W., & Wang, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118879 · Cited by 27
Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies
Yang, Z., Deng, W., Zhang, X., An, Y., Liu, Y., Yao, H., & Zhang, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.789330 · Cited by 27
Quantifying uncertainties in the microvascular transport of nanoparticles
Lee, T.-R., Greene, M. S., Jiang, Z. M., Kopacz, A. M., Decuzzi, P., Chen, W., & Liu, W. K. (2013) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-013-0513-0 · Cited by 27
Zhang, L., Hao, P., Yang, D., Feng, S., Peng, B., Appelhans, D., Zhang, T., & Zan, X. (2019) · Journal of Materials Chemistry B · doi:10.1039/c8tb03034k · Cited by 26
Möckel, D., Bartneck, M., Niemietz, P. M., Wagner, M., Ehling, J., Rama, E., Weiler, M., Gremse, F., Eulberg, D., Pola, R., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.044 · Cited by 26
Improving Tumor Targeting and Penetration for Nanoparticle‐Mediated Cancer Therapy
Luo, Z., Chen, C., & Li, S. (2025) · Small Methods · doi:10.1002/smtd.202401860 · Cited by 28
Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours
Mo, S., Carlisle, R. C., Laga, R., Myers, R. S., Graham, S., Cawood, R., Ulbrich, K., Seymour, L. W., & Coussios, C. C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.265 · Cited by 26
Hashimoto, M., Tong, R., & Kohane, D. S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300652m · Cited by 28
Zhan, W. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.12.065 · Cited by 25
Xue, F., Dixon, H., Glen‐Ravenhill, H., Karaosmanoglu, S., Li, Q., Yan, L., & Chen, X. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900093 · Cited by 26
Singh, M. S., Goldsmith, M., Thakur, K., Chatterjee, S., Landesman‐Milo, D., Levy, T., Kunz‐Schughart, L. A., Barenholz, Y., & Peer, D. (2019) · Nanoscale · doi:10.1039/c9nr09572a · Cited by 26
Zhang, Y., Wang, G., Li, Q., Jiang, Y., Chen, W., Zhao, M., Liang, G., & Miao, Q. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c21860 · Cited by 26
A cerebellar window for intravital imaging of normal and disease states in mice
Askoxylakis, V., Badeaux, M. D., Roberge, S., Batista, A., Kirkpatrick, N., Snuderl, M., Amoozgar, Z., Seano, G., Ferraro, G. B., Chatterjee, S., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2017.101 · Cited by 27
Self-citationStable, small, specific, low-valency quantum dots for single-molecule imaging
Lee, J., Feng, X., Chen, O., Bawendi, M. G., & Huang, J. (2018) · Nanoscale · doi:10.1039/c7nr08673c · Cited by 25
Self-citationShariati, M., Willaert, W., Ceelen, W. P., Smedt, S. C. D., & Remaut, K. (2019) · Cancers · doi:10.3390/cancers11070906 · Cited by 25
Self-degrading graphene sheets for tumor therapy
Donskyi, I. S., Chen, Y., Nickl, P., Guday, G., Qiao, H., Achazi, K., Lippitz, A., Unger, W. E. S., Böttcher, C., Chen, W., et al. (2020) · Nanoscale · doi:10.1039/d0nr02159h · Cited by 25
Hare, J. I., Moase, E. H., & Allen, T. M. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.729215 · Cited by 25
Casein modified gold nanoparticles for future theranostic applications
Espinoza-Castañeda, M., de la Escosura‐Muñiz, A., González‐Ortiz, G., Martín-Orúe, S. M., Pérez, J. F., & Merkoçi, A. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.07.042 · Cited by 25
Advances in mathematical models of the active targeting of tumor cells by functional nanoparticles
Gao, Y., Shi, Y., Wang, L., Kong, S., Du, J., Lin, G., & Feng, Y. (2019) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2019.105106 · Cited by 25
Mathematical modelling of hollow microneedle-mediated transdermal drug delivery
Benbrook, N., & Zhan, W. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01801-3 · Cited by 24
Kashkooli, F. M., Bhandari, A., Gu, B., Kolios, M. C., Kohandel, M., & Zhan, W. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114138 · Cited by 28
Sub-15 nm Nanoparticles for Drug Delivery: Emerging Frontiers and Therapeutic Potential
De, T., Trieu, V. N., Myers, S., Qazi, S., Saund, S., & Lee, C. W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210842 · Cited by 26
Pandey, A., Sarangi, S., Chien, K. S., Sengupta, P., Papa, A., Basu, S., & Sengupta, S. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/44/445101 · Cited by 24
Mason‐Osann, E., Hollevoet, K., Niederfellner, G. J., & Pastan, I. H. (2015) · Scientific Reports · doi:10.1038/srep10832 · Cited by 24
Moya‐Garcia, C. R., Li‐Jessen, N. Y. K., & Tabrizian, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129902 · Cited by 25
Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications
Ding, J., Ding, X., Liao, W., & Lu, Z. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100913 · Cited by 27
Sharmila, A., Roopan, S. M., & Selvaraj, C. I. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105731 · Cited by 24
Štaka, I., Cadete, A., Surikutchi, B. T., Abuzaid, H., Bradshaw, T. D., Alonso, M. J., & Marlow, M. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.070 · Cited by 24
Tumor-triggered personalized microRNA cocktail therapy for hepatocellular carcinoma
Shao, S., Hu, Q., Wu, W., Wang, M., Huang, J., Zhao, X., Tang, G., & Liang, T. (2020) · Biomaterials Science · doi:10.1039/d0bm00794c · Cited by 24
Naidu, E. C., Olojede, S. O., Lawal, S. K., Rennie, C. O., & Azu, O. O. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.776 · Cited by 25
Tuning the In Vivo Transport of Anticancer Drugs Using Renal‐Clearable Gold Nanoparticles
Peng, C., Xu, J., Yu, M., Ning, X., Huang, Y., Du, B., Hernandez, E., Kapur, P., Hsieh, J., & Zheng, J. (2019) · Angewandte Chemie · doi:10.1002/ange.201903256 · Cited by 24
Understanding biophysical behaviours of microfluidic-synthesized nanoparticles at nano-biointerface
Soleimani, S., Hasani‐Sadrabadi, M. M., Majedi, F. S., Dashtimoghadam, E., Tondar, M., & Jacob, K. I. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.06.002 · Cited by 23
MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment
Yang, J., Liao, C., Liu, Y., Yang, G., Ke, T., Ding, Y., & Li, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.22600 · Cited by 23
Shen, C., Nethi, S. K., Al‐Kofahi, M., & Prabha, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010092 · Cited by 23
Bina, A., Raissi, ., Hashemzadeh, H., & Farzad, F. (2021) · RSC Advances · doi:10.1039/d1ra02361f · Cited by 23
Mehany, H. M., El‐Shafai, N. M., Attia, A. M., Ibrahim, M. M., & El‐Mehasseb, I. M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.06.171 · Cited by 23
Mamun, A. A., Uddin, M. S., Perveen, A., Jha, N. K., Alghamdi, B. S. A., Jeandet, P., Zhang, H., & Ashraf, G. M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.08.007 · Cited by 24
Translational nanomedicine potentiates immunotherapy in sarcoma by normalizing the microenvironment
Mpekris, F., Panagi, M., Michael, C., Voutouri, C., Tsuchiya, M., Wagatsuma, C., Kinoh, H., Osada, A., Akinaga, S., Yoshida, S., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.016 · Cited by 24
Self-citationNakamura, H., Doi, Y., Lila, A. S. A., Nagao, A., Ishida, T., & Kiwada, H. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.007 · Cited by 23
Downsizing tumour therapeutics
Cheng, C. J., & Saltzman, W. M. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.89 · Cited by 23
Okamatsu, A., Motoyama, K., Onodera, R., Higashi, T., Koshigoe, T., Shimada, Y., Hattori, K., Takeuchi, T., & Arima, H. (2013) · Biomacromolecules · doi:10.1021/bm401340g · Cited by 23
Dimensionality of carbon nanomaterial impacting on the modulation of amyloid peptide assembly
Wang, J., Zhu, Z., Bortolini, C., Hoffmann, S. V., Amari, A., Zhang, H. X., Liu, L., & Dong, M. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/30/304001 · Cited by 23
Potential drug delivery nanosystems for improving tumor penetration
Peng, F., Li, R., Zhang, F., Qin, L., Ling, G., & Zhang, P. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.04.009 · Cited by 23
Multi-objective optimization of tumor response to drug release from vasculature-bound nanoparticles
Chamseddine, I. M., Frieboes, H. B., & Kokkolaras, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-65162-2 · Cited by 22
Katō, Y., Zhu, W., Backer, M. V., Neoh, C. C., Hapuarachchige, S., Sarkar, S. K., Backer, J. M., & Artemov, D. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1736-9 · Cited by 23
Anti-lymphangiogenesis for boosting drug accumulation in tumors
Wang, C., Xu, J., Cheng, X., Sun, G., Li, F., Nie, G., & Zhang, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01794-4 · Cited by 24
Sun, Y., Yin, Z., Li, S., Wu, L., Zhang, Y., Zhao, Y., SANTOS, I. L. G. D., Subudhi, S., Lei, P., Muzikansky, A., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02863-9 · Cited by 23
Self-citationTreating breast cancer metastasis with cabazitaxel-loaded polymeric micelles
Zhong, T., He, B., Cao, H., Tan, T., Hu, H., Li, Y., & Zhang, Z. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.36 · Cited by 22
Enhanced nanodrug delivery in tumors after near‐infrared photoimmunotherapy
Inagaki, F. F., Furusawa, A., Choyke, P. L., & Kobayashi, H. (2018) · Nanophotonics · doi:10.1515/nanoph-2019-0186 · Cited by 22
Li, Y., Liu, Y., Du, B., & Cheng, G. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00077 · Cited by 22
Cancer Nanomedicine and Immune System—Interactions and Challenges
Ahmad, S., Idris, R. A. M., Hanaffi, W. N. W., Perumal, K., Boer, J. C., Plebanski, M., Jaafar, J., Lim, J., & Mohamud, R. (2021) · Frontiers in Nanotechnology · doi:10.3389/fnano.2021.681305 · Cited by 22
Wang, X., Niu, X., Sha, W., Feng, X., Yu, L., Zhang, Z., Wang, W., & Yuan, Z. (2021) · Biomaterials Science · doi:10.1039/d1bm00834j · Cited by 22
Cho, S., Sun, Y., Soisson, A. P., Dodson, M. K., Peterson, C. M., Jarboe, E. A., Kennedy, A., & Janat-Amsbury, M. M. (2013) · PubMed · Cited by 22
Targeting metastasis with nanomedicine
Pallares, R. M., Consolino, L., Wang, A., Lorenzi, F. D., Kiessling, F. M., Schroeder, A., & Lammers, T. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00358-7 · Cited by 28
Pöschinger, T., Renner, A., Eisa, F., Dobosz, M., Strobel, S., Weber, T. G., Brauweiler, R., Kalender, W. A., & Scheuer, W. (2014) · Investigative Radiology · doi:10.1097/rli.0000000000000038 · Cited by 21
Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment
Hameed, S., Bhattarai, P., & Dai, Z. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9256-1 · Cited by 21
Zhang, C., Men, D., Zhang, T., Yu, Y., Xiang, J., Jiang, G., & Hang, L. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b20677 · Cited by 21
Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer
Halder, J., Pradhan, D., Biswasroy, P., Rai, V. K., Kar, B., Ghosh, G., & Rath, G. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2095389 · Cited by 22
Magnetic Resonance Imaging of Tumor with a Self-Traceable Phosphorylcholine Polymer
Yamada, H., Hasegawa, Y., Imai, H., Takayama, Y., Sugihara, F., Matsuda, T., Tochio, H., Shirakawa, M., Sando, S., Kimura, Y., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/ja510479v · Cited by 21
Stress alleviation strategy in cancer treatment: Insights from a mathematical model
Mpekris, F., Voutouri, C., Papageorgis, P., & Stylianopoulos, T. (2018) · ZAMM ‐ Journal of Applied Mathematics and Mechanics / Zeitschrift für Angewandte Mathematik und Mechanik · doi:10.1002/zamm.201700270 · Cited by 21
Self-citationGuo, W., Chen, J., Liu, L., Eltahan, A. S., Rosato, N., Yu, J. X., Wang, D., Chen, J., Bottini, M., & Liang, X. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b16395 · Cited by 21
Metadata
- Authors
- Chauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Massachusetts Institute of Technology (US)
- Corresponding author
- Jain, Rakesh K.
- ORCID
- Venue
- Nature Nanotechnology
- Published
- 2012-04-08
- Volume
- 7
- Issue
- 6
- Pages
- 383-388
- ISSN
- 1748-3387 (ISSN-L)
- 1748-3395
- PMC
- PMC3370066
- OpenAlex
- W2126163864
- Semantic Scholar
- 0d1831c2f5786af72e65cfee65362aec9f4a2b84
- Cited by
- 1,101
- References
- 31
- Citations by year
- 2026: 41 · 2025: 41 · 2024: 69 · 2023: 76 · 2022: 80 · 2021: 103 · 2020: 102 · 2019: 107 · 2018: 89 · 2017: 76 · 2016: 73 · 2015: 71 · 2014: 68 · 2013: 78 · 2012: 26
- FWCI
- 31.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Nanotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Cancer Institute (R01CA115767, T32CA073479, R01CA085140, R01CA096915, R24CA085140, P01CA080124, R01CA126642, R01CA098706)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- anti-angiogenic therapy, nanomedicine delivery, nanoparticle size dependence, interstitial fluid pressure, tumor penetration, tumor vasculature, steric hindrance, mammary tumors
- MeSH terms
- Animals, Female, Mammary Neoplasms, Experimental, Drug Delivery Systems, Mice, SCID, Angiogenesis Inhibitors, Receptors, Vascular Endothelial Growth Factor, Nanomedicine, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review